VatcheTchekmedyianMD

Physician

Dr. Tchekmedyian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
265 Western Ave
South Portland, ME 04106
Phone+1 207-661-0200

Fax+1 207-661-0299

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2019
Brigham and Women's HospitalResidency, Internal Medicine, 2011 - 2014
David Geffen School of Medicine at UCLAClass of 2011

PubMed

14 citations
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.
Glenn J Hanna, Harita Dharanesswaran, Anita Giobbie-Hurder, John J Harran, Zixi Liao
Journal of Clinical Oncology. 2024-03-20
14 citations
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.
Joris L Vos, Bharat Burman, Swati Jain, Conall W R Fitzgerald, Eric J Sherman
Nature Medicine. 2023-12-01
27 citations
Enhancing Radioiodine Incorporation in-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pi...
Vatche Tchekmedyian, Lara Dunn, Eric Sherman, Shrujal S Baxi, Ravinder K Grewal
Thyroid. 2022-03-01

Lectures

A retrospective analysis of cisplatin dosing strategies when used with radiation on outcomes in head and neck squamous cell carcinoma of the oropharynx.
2019 ASCO Annual Meeting - 6/1/2019
A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC).
2019 ASCO Annual Meeting - 6/1/2019
A phase II study of lenvatinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018